Pioglitazone
TPNA 02-037A
Approved small_molecule completed
Quick answer
Pioglitazone for Diabetes Type 2 is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Diabetes Type 2
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed